Mergers & AcquisitionsMedium•16 October 2026•
1 min read
Sanara MedTech-MiMedx Deal Spread Widens After FTC Second Request
Key Facts
1The deal spread for the Sanara MedTech and MiMedx merger widened following a 'second request' for information from the Federal Trade Commission (FTC).
The deal spread for the merger between Sanara MedTech and MiMedx widened following a second request for information from the Federal Trade Commission (FTC). Seeking Alpha reported that the regulatory move has increased uncertainty regarding the transaction, leading to a significant expansion in the arbitrage spread.
SMTI closed at $35.09 on October 15, 2026, while MDXG closed at $4.68 on the same date. A second request from the FTC typically indicates an extended antitrust investigation, which increases the risk of the deal being delayed or facing potential regulatory hurdles.